Ovarian Cancer Prognosis

prognosis for stage 111 ovarian Cancer at age 33?

i am a hospice nurse who has just learned today that my 33 year old daughter in law has stage three Ovarian Cancer. she is to have surgery on weds. nd i am sure that there will be further staging done. i am distraught over this dx as is my son, husband and the rest of the family. jennifer has two children, ages 14 and 10 . i need to know how long she might have to spend with them and us. i want to make whatever time that she has be the best time fo her life.

The 5-year-Survival Rate is a statistical way of looking at the death rate in a cancer. You can look it up online (I have to say, it is a rather depressingly low number) but please keep this in mind: It cannot tell you anything about your daughter’s individual chances since statistics only deal with groups.
Some people can die from othe Stage 2 Cancer in 6 months, others will live with a Stage 4 Cancer for 10 years.
Your best bet is an honest discussion with the oncologist but always keep in mind, noone can give you an absolute number. They just don’t know. How you react to treatment, how fast the cancer grows – it is different for different woman.
My mother died last year of ovarian cancer, between diagnosis stage IV and death were only 9 months. In this time we just did our best to be there for her, helped her with everyday work as much as possible, talked to her when and about what she wanted – including death. Towards the end we all put our lifes on hold while hers ran out, just to be there for her. Most people aren’t lucky enough to be able to do this. But she was very grateful to have her family to rely on. I don’t believe this is much of a comfort for you.
I wish you and your daughter the very best of luck.

Ovarian Cancer Prognosis and the One Minute Cure.wmv

Facing Ovarian Cancer (PAL) $75.00 A woman’s guide to ovarian cancer – symptoms, diagnosis, treatment & support (2 hrs). Essential for all gynae-oncological wards and for all women who have been diagnosed and their carers.Ovarian cancer is the sixth most common cause of cancer death in women. Approximately 1 in every 100 women will develop this disease – mostly women over the age of 45, although it can also occur in younger women. …

Facing Ovarian Cancer (NTSC) $75.00 A woman’s guide to ovarian cancer – symptoms, diagnosis, treatment & support (2 hrs). Essential for all gynae-oncological wards and for all women who have been diagnosed and their carers.Ovarian cancer is the sixth most common cause of cancer death in women. Approximately 1 in every 100 women will develop this disease – mostly women over the age of 45, although it can also occur in younger women. …

Complementary/Holistic Medicine for Ovarian Cancer – It’s Your Life, Live It! $83.71 This book will show you the most successful alternative, natural & complimentary cancer treatments available today for Ovarian cancer.To that end, you won’t find a better warrior in the war on cancer than reading this book.We are honored to inform you that many leading hospitals use our books in their medical library to be used by physicians. They are Harvard University, Columbia, NYU, UCLA, Johns…

CA 125 predicts survival in ovarian Ca patients.(GYNECOLOGY): An article from: OB GYN News $9.95 This digital document is an article from OB GYN News, published by International Medical News Group on May 1, 2010. The length of the article is 545 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available immediately after purchase. You can view it with any web browser.Citation DetailsTitle: CA 125 predicts survival in ovaria…

Methods of Cancer Diagnosis, Therapy, and Prognosis: Ovarian Cancer, Renal Cancer, Urogenitary tract Cancer, Urinary Bladder Cancer, Cervical Uterine … Leukemia, Multiple Myeloma and Sarcoma $209.15 This sixth volume in the series Methods of Cancer Diagnosis, Therapy, and Prognosis discusses Ovarian Cancer, Renal Cancer, Urogenitary Cancer, Urinary Bladder Cancer, Cervical Uterine Cancer, Skin Cancer, Leukemia, Multiple Myeloma and Sarcoma. Both standard and emerging therapies for these cancers, written by expert oncologists/pathologists in this field, are included. This fully illustrated …